Covid-19

Singapore to contribute US$5 mil to support less wealthy countries' access to vaccine - THE EDGE SINGAPORE

Covid-19

Singapore to contribute US$5 mil to support less wealthy countries' access to vaccine

Singapore will contribute US$5 million ($6.67 million) to the Covid-19 Vaccine Global Access (COVAX) Advance Market Commitment (AMC) mechanism, which will help support 92 low- and lower-middle-inco

Here’s where Pfizer's vaccine stands in Asia - THE EDGE SINGAPORE

Covid-19

Here's where Pfizer's vaccine stands in Asia

The quick approval of Pfizer Inc.’s coronavirus vaccine in the UK isn’t likely to accelerate the availability of the shot in Asia, as countries work to complete local safety tests and negotiate dea

Covid-19

Merck sells stake in Moderna as vaccine gets FDA review

Merck & Co. said it sold its stake in Moderna Inc., the biotechnology company that’s in the midst of developing a Covid-19 vaccine. The shares of both companies rose.

Covid-19

UK becomes first western country to clear Pfizer-BioNTech Covid-19 vaccine

The UK became the first western country to approve a Covid-19 vaccine, with its regulator clearing Pfizer Inc. and BioNTech SE’s shot ahead of decisions in the US and European Union.

UG Healthcare to conduct Covid-19 testing on employees as precautionary measure - THE EDGE SINGAPORE

Covid-19

UG Healthcare to conduct Covid-19 testing on employees as precautionary measure

UG Healthcare announced on Dec 1 that it will be conducting Covid-19 testing on its employees in its upstream manufacturing operations based in Malaysia.

Covid-19

BioNTech gets downgrade from analyst amid vaccine competition

A BioNTech SE analyst advised investors to cash in on their profits from the US$30 billion ($40.15 billion) biotech’s recent advance, saying the German company now faces heightened competition from

Hong Kong-Singapore travel bubble delayed further amid virus - THE EDGE SINGAPORE

Covid-19

Hong Kong-Singapore travel bubble delayed further amid virus

Hong Kong and Singapore further delayed the keenly anticipated travel corridor between the Asian financial hubs, a setback for the region’s airlines and tourism businesses seeking to start a recove

Small is better for vaccine shares - THE EDGE SINGAPORE

Covid-19

Small is better for vaccine shares

Investors who bet on success in the race to develop coronavirus vaccines are finding that smaller is better.

Navigating the complexity of climate risk during pandemic times - THE EDGE SINGAPORE

Covid-19

Navigating the complexity of climate risk during pandemic times

Even though Covid-19 still dominates global news cycles, we must not neglect other serious risks affecting our world, most notably climate change.

Covid-19

Oxford study confirms Astra Covid shot’s strong immune response in elderly

The University of Oxford confirmed that the Covid-19 vaccine it’s developing with AstraZeneca Plc produced strong immune responses in older adults in an early study, with key findings from the last

Be informed of the stories that matter

×